A model-informed target product profile for population modification gene drives for malaria control

Agastya Mondal,Hector Manuel Sanchez Castellanos,John Macky Marshall

DOI: https://doi.org/10.1101/2024.08.16.24312136

2024-08-19

Abstract:As reductions in malaria transmission in sub-Saharan Africa stagnate, gene drive-modified mosquitoes represent one of the most promising novel tools for continued disease control. In order to advance from the laboratory to the field, gene drives will be assessed against target product profiles, planning tools that list minimum criteria products should satisfy as they progress through the development pipeline. Here, we use an eco-epidemiological model to investigate parameter values for population modification gene drives that satisfy two previously-discussed target outcomes: a 50% reduction in clinical malaria incidence for a duration (window-of-protection) of at least three years, and a time-to-impact of less than one year. We consider two African settings, Burkina Faso and Kenya, where gene drive mosquitoes are currently being researched, and consider three transmission intensities at each. For the gene drive product, we explore rates of homing and resistance allele generation, fitness costs associated with gene drive and non-functional resistance alleles, and the efficacy of the effector gene(s) at reducing mosquito-to-human transmission. We find that when the window-of-protection criterion is satisfied, the time-to-impact criterion also is. Target outcomes are most influenced by the fitness cost associated with the gene drive allele and effector gene efficacy. Resistance allele parameters are also highly influential on target outcomes, and determine how long the gene drive allele persists in the population after most available wild-type alleles have been cleaved. Low rates of functional resistance allele generation are preferred, while costly non-functional resistance alleles will allow the drive allele to outcompete them. Homing rates already achieved for Anopheles gene drives do not need to be improved upon. A conundrum exists whereby the most important product parameters for predicting field efficacy are those that can only be reliably measured in the field, which presents a challenge for assessment of product readiness.

What problem does this paper attempt to address?

The paper attempts to address whether gene drive mosquitoes can meet specific Target Product Profiles (TPPs) in malaria control to achieve a significant reduction in malaria incidence. Specifically, the study explores the parameter values of gene drive mosquitoes in two African environments (Burkina Faso and Kenya) through an eco-epidemiological model, which can meet the following two target outcomes:

1. Reduce clinical malaria cases by 50% for at least 3 years;
2. The time to achieve the effect (time from release to 50% reduction in cases) does not exceed 1 year.

The study aims to identify which parameters are most critical to achieving these goals and discusses how to assess the readiness of gene drive products, especially the challenges between laboratory measurements and actual field effects. Additionally, the study uses the MGDrivE 3 framework to simulate the effects of gene drive mosquito releases under different parameters, analyzing the main influencing factors and their contributions to the target outcomes.